Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Citius Oncology, Inc. (CTOR) had Free Cash Flow per Share of $-0.13 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$1.49M |
|
$-8.92M |
|
$0.49M |
|
$1.00M |
|
$10.21M |
|
$-8.72M |
|
$-0.31M |
|
$-9.03M |
|
$-9.03M |
|
$-8.92M |
|
$-8.92M |
|
$-8.92M |
|
$-8.92M |
|
$-8.72M |
|
$-6.82M |
|
107.89M |
|
107.89M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$42.71M |
|
-- |
|
$69.39M |
|
$112.09M |
|
$58.79M |
|
$10.21M |
|
$12.92M |
|
$71.71M |
|
$40.38M |
|
$40.38M |
|
$40.38M |
|
105.76M |
|
| Cash Flow Statement Financials | |
$-13.90M |
|
$-7.00M |
|
$33.54M |
|
$3.92M |
|
$16.56M |
|
$12.64M |
|
$11.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.73 |
|
-- |
|
-- |
|
0.20 |
|
0.50 |
|
67.07% |
|
-583.54% |
|
-583.54% |
|
-- |
|
-604.58% |
|
-597.40% |
|
$-13.90M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
2.18 |
|
41.35 |
|
-22.10% |
|
-22.10% |
|
-7.96% |
|
-17.64% |
|
$0.38 |
|
|
Free Cash Flow per Share |
$-0.13 |
$-0.13 |
|